Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018799 (
heart disease
)
34,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The HECT E3 ubiquitin ligase
HACE1
is a tumour suppressor known to regulate Rac1 activity under stress conditions.
HACE1
is increased in the serum of patients with heart failure. Here we show that
HACE1
protects the heart under pressure stress by controlling protein degradation. Hace1 deficiency in mice results in accelerated heart failure and increased mortality under haemodynamic stress. Hearts from Hace1(-/-) mice display abnormal cardiac hypertrophy, left ventricular dysfunction, accumulation of LC3, p62 and ubiquitinated proteins enriched for cytoskeletal species, indicating impaired autophagy. Our data suggest that
HACE1
mediates p62-dependent selective autophagic turnover of ubiquitinated proteins by its ankyrin repeat domain through protein-protein interaction, which is independent of its E3 ligase activity. This would classify
HACE1
as a dual-function E3 ligase. Our finding that
HACE1
has a protective function in the heart in response to haemodynamic stress suggests that
HACE1
may be a potential diagnostic and therapeutic target for
heart disease
.
...
PMID:HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress. 2461 89